Monroe named director, Division of Reproductive and Urologic Products.

Scott Monroe, M.D., has accepted the position of Director of the Division of Reproductive and Urologic Products (DRUP). Monroe has been serving as the acting Director for DRUP since June 2006.

Monroe obtained his undergraduate and medical education at the University of Michigan (body, education) University of Michigan - A large cosmopolitan university in the Midwest USA. Over 50000 students are enrolled at the University of Michigan's three campuses. The students come from 50 states and over 100 foreign countries. . After completing a fellowship in reproductive endocrinology at the University of Pittsburgh and residency training in Obstetrics and Gynecology obstetrics and gynecology

Medical and surgical specialty concerned with the management of pregnancy and childbirth and with the health of the female reproductive system. at the University of Michigan, he became a full-time faculty member in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). San Francisco (UCSF). His positions in the pharmaceutical industry have included head of the Department of Reproductive Medicine and director of Clinical Research and Medical Affairs.

Monroe joined FDA FDA
abbr.
Food and Drug Administration

FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration. in 2000 as a Medical Officer in DRUP. He was subsequently promoted to Medical Team Leader in 2002, Deputy Division Director in 2005 and acting Division Director in 2006. His expertise in reproductive medicine has been recognized by his appointment as a permanent member of a NIH "Not invented here." See digispeak.

NIH - The United States National Institutes of Health. study section, and his selection as a reviewer/consultant for several NIH special study sections. He has authored more than 50 publications in the area of reproductive medicine.

COPYRIGHT 2007 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:	FDA management
Publication:	Adverse Event Reporting News
Article Type:	Brief article
Geographic Code:	1USA
Date:	Oct 8, 2007
Words:	192
Previous Article:	Francis named Deputy Director of Office of Surveillance and Epidemiology.(FDA management)(Brief article)
Next Article:	FDA's Woodcock honored by Alliance.(FDA management)(Brief article)
Topics:	Government officials Appointments, resignations and dismissals Public officers Appointments, resignations and dismissals

Related Articles
Conflicts Abound in Choice to Head FDA Division Handling RU 486.
'Good Tissue Practice' rules may mean CBER team inspections.
Networking to create the future we want: reports from reproductive health advocacy meetings.
Access to abortion: beyond the legal guarantees of Roe.
MEDICAL MEMOS.(HEALTH)
NTP draft brief on DEHP.(NIEHS News)
CAPAs and risk analysis flaws net 8-item write up.(Medical devices)
Names in the News.(Janet Woodcock has been named director of the US Food and Drug Administration)(Cynthia Siljestrom has been named Chief Executive...